Report Calls for Initiative to Establish a World-leading UK Microbiome Biobank We’re pleased to announce the release of a new NBIC-facilitated report from CABI Agriculture and Bioscience. The report calls for a “highly ambitious enterprise” to create a microbiome...
Innovative Businesses Secure Funding After Completing LYVA Labs’ Microbials Accelerator Programme Nine innovative businesses are celebrating receiving £857,000 in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’...
Target Product Profiles for Diagnostics The Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate recently launched their diagnostic target product profiles (TPPs) detailing key characteristics of new tests needed to detect and manage lung infections in CF. A...
Combating antibiotic resistance Antibiotics are used to treat or prevent some types of bacterial infection. They are becoming less effective due to overuse in recent years. NBIC Research Fellow, Dr Callum Highmore, and researchers at the NIHR Southampton Biomedical...
Major Research and Innovation Infrastructure Investment for the University of Liverpool The University of Liverpool will lead a new £125 million national research facility to drive forward scientific discoveries and technological advances in areas such as sustainable...
